Skip to content

Clinical trials

Observational Leukemia, Myeloid, Chronic-Phase trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Chronic-Phase Phase: Observational Country / region: United States Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20063
20072
20085
20093
20103
20171
20191
20201
20231
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated8
Recruiting3
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
City of Hope Medical Center4
Vanderbilt-Ingram Cancer Center3
Bristol-Myers Squibb2
Case Comprehensive Cancer Center2
Novartis Pharmaceuticals2
SWOG Cancer Research Network2
UNC Lineberger Comprehensive Cancer Center2
Vanderbilt University2
Columbia University1
Dana-Farber Cancer Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Chronic-Phase28
Leukemia, Myeloid, Accelerated Phase21
Blast Crisis20
Leukemia, Lymphocytic, Chronic, B-Cell20
Precursor Cell Lymphoblastic Leukemia-Lymphoma20
Leukemia, Myeloid, Acute19
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative19
Leukemia, Myelomonocytic, Chronic19
Congenital Abnormalities18
Myeloproliferative Disorders18

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.